Background This exploratory case-control study is to evaluate the effects of supplementation
of Aureobasidium pullulans-N-163 strain produced 1, 3–1,− 6 beta glucan in young patients …

Background Duchenne muscular dystrophy (DMD) is an inherited neuromuscular disorder
causing progressive muscle weakness and premature death. Steroids remain the …

Duchenne muscular dystrophy (DMD) is a debilitating genetic disease that causes gradual
muscle weakening and early mortality. After a 45-day clinical pilot study and a pre-clinical …

Background Muscular dystrophies other than Duchenne muscular dystrophy (DMD) are
genetic diseases characterized by increasing muscle weakness, loss of ambulation, and …

Objective Duchenne muscular dystrophy (DMD) is an X-linked neuromuscular disorder that
leads to increasing muscle weakening and early death. Steroids, the standard treatment of …

Introduction Duchenne muscular dystrophy (DMD) is a X-linked fatal myogenic disorder, in
which lack of dystrophin leads to significant fibrosis and a progressive loss of muscle mass …

Recent advances in the management of Duchenne muscular dystrophy (DMD), such as
exon skipping and gene therapy, though have reached a clinical stage, the outcome at its …

Background Duchenne muscular dystrophy is a hereditary muscular disease involving
degeneration (ie atrophy and loss of muscle fibres) of skeletal muscles, including the …

The beneficial immunomodulation effects of a biological response modifier glucan (BRMG)
produced by two strains of Aureobasidium pullulans, AFO-202 and N-163, have already …

Duchenne muscular dystrophy (DMD) is a severe and progressive muscle wasting disorder,
affecting one in 3500 to 5000 boys worldwide. The NO-sGC-cGMP pathway plays an …